STRIVERDI RESPIMAT

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug STRIVERDI RESPIMAT contains one active pharmaceutical ingredient (API):

1	Olodaterol UNII 65R445W3V9 - OLODATEROL HYDROCHLORIDE
	Olodaterol has a high affinity and high selectivity to the human beta2-adrenoceptor. The compound exerts its pharmacological effects by binding and activation of beta2-adrenoceptors after topical administration by inhalation. Activation of these receptors in the airways results in a stimulation of intracellular adenyl cyclase, an enzyme that mediates the synthesis of cyclic-3',5' adenosine monophosphate (cAMP). Elevated levels of cAMP induce bronchodilation by relaxation of airway smooth muscle cells.
	Read more about Olodaterol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STRIVERDI RESPIMAT Inhalation solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AC19		R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	504514100019602
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	13832831, 16023457, 16023463, 16060151, 16060168, 16362975, 16362981
EE	Ravimiamet	1583355, 1583366, 1583377, 1583388
ES	Centro de información online de medicamentos de la AEMPS	78253
FI	Lääkealan turvallisuus- ja kehittämiskeskus	030584
FR	Base de données publique des médicaments	64559568
GB	Medicines & Healthcare Products Regulatory Agency	246081, 376784
HK	Department of Health Drug Office	63776
IE	Health Products Regulatory Authority	46893, 46894
LT	Valstybinė vaistų kontrolės tarnyba	1086464, 1086465, 1086466, 1086467
MT	Medicines Authority	MA211/00401
NL	Z-Index G-Standaard, PRK	113166
PL	Rejestru Produktów Leczniczych	100308670
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60771001, W60771005, W60771006, W60771007
SG	Health Sciences Authority	14553P
US	FDA, National Drug Code	0597-0192